Brief: Pledpharma Prepares For Listing On Nasdaq Stockholm Main Market In 2019
Dec 5 (Reuters) - PledPharma AB (publ) PLED.ST :
* REG-PLEDPHARMA PREPARES FOR LISTING ON THE NASDAQ
STOCKHOLM MAIN
MARKET DURING 2019
* DECIDED TO INITIATE A PROCESS TO ENABLE LISTING OF
COMPANY'S
SHARE ON NASDAQ STOCKHOLM'S MAIN MARKET IN 2019
Source text for Eikon: ID:nGNE3g4btJ
Further company coverage: PLED.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Egetis Therapeutics AB (publ)
See all newsBrief: Egetis Announces Grant Of Patent For MCT8 Deficiency Composition In U.S.
Swedisg drugmaker Egetis's Q1 revenue rises 9% on Emcitate sales in Europe
Brief: Egetis Therapeutics Q1 Loss SEK 94.5 Mln
Brief: Egetis Plans Directed Share Issue Raising SEK 350 Million
Brief: Egetis Therapeutics Appoints Tiago Nunes As CMO Effective May 1